Mammaglobin gene expression: A superior marker of breast cancer cells in peripheral blood in comparison to epidermal- growth-factor receptor and cytokeratin-19

Laboratory Investigation

Volumn 80, Issue 7, 2000, Pages 1071-1077

  Grünewald, Kurt ^a   Haun, Margot ^a   Urbanek, Martina ^a   Fiegl, Michael ^a   Müller Holzner, Elisabeth ^b   Gunsilius, Eberhard ^a   Dünser, Martina ^b   Marth, Christian ^b   Gastl, Günther ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMAGLOBIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL ISOLATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0343953069     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780112     Document Type: Article

References (17)

1. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, and Hoon DS (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640.
2. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, and Selby P (1995). Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71:278-281.
3. Cailleau R, Olive M, and Cruciger QV (1978). Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14:911-915.
4. Chelly J, Concordet JP, Kaplan JC, and Kahn A (1989). Illegitimate transcription: Transcription of any gene in any cell type. Proc Natl Acad Sci USA 86:2617-2621.
5. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, and Roth MS (1994). Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482.
6. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, and Bastert G (1992). Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10:1534-1539.
7. Eltahir EM, Mallinson DS, Birnie GD, Hagan C, George WD, and Purushotham AD (1998). Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer 77:1203-1207.
8. Krismann M, Todt B, Schroder J, Gareis D, Muller KM, Seeber S, and Schutte J (1995). Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775.
9. Kruger W, Krzizanowski C, Holweg M, Stockschlader M, Kroger N, Jung R, Mross K, Jonat W, and Zander AR (1996). Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122:679-686.
10. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles TJ, and Coombes RC (1987). Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) 295:1093-1096.
11. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, and Riethmuller G (1993). Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424.
12. Pantel K, Cote RJ, and Fodstad O (1999). Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124.
13. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, and Coombes RC (1994). Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990.
14. Watson MA, Darrow C, Zimonjic DB, Popescu NC, and Fleming TP (1998). Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16:817-824.
15. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, and Fleming TP (1999). Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59:3028-3031.
16. Watson MA and Fleming TP (1996). Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56:860-865.
17. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, and Lutz D (1999). Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 17: 2015-2019.